| Pharmaceutical active ingredients: |
| Cisplatin |
| Available forms, composition and doses of Briplatin: |
| N / A |
| Briplatin medical category: |
| Human:Antineoplastic agentsCytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01XA01 - Cisplatin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Brij | Laureth-9 | Unidentified Pharmaceutical Company |
| Brillfast Violet | Methyl Violet | Unidentified Pharmaceutical Company |
| Brilliant Violet 5B | Gentian Violet | Unidentified Pharmaceutical Company |
| Brimstone | Sulfur | Unidentified Pharmaceutical Company |
| Brinolase | Brinase | Unidentified Pharmaceutical Company |
| Bristab | Furosemide; Hydroflumethiazide | Unidentified Pharmaceutical Company |
| Bristaciclin | Tetracycline | Unidentified Pharmaceutical Company |
| Bristaline | Methdilazine | Unidentified Pharmaceutical Company |
| Bristamin | Phenyltoloxamine | Unidentified Pharmaceutical Company |
| Bristuric | Bendroflumethiazide | Unidentified Pharmaceutical Company |